|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
AvidBiotics Sees New Angle for Personalized Medicine in Antibiotics
|
Luke Timmerman |
02/01/12 |
San Francisco
|
|
Optimer, Following Pfizer’s Playbook, Has Big Plans for Antibiotic
|
Luke Timmerman |
01/31/12 |
San Diego
|
|
San Diego Life Sciences Roundup: BeneChill, Sotera, Imthera, & More
|
Bruce V. Bigelow |
12/16/11 |
San Diego
|
|
Optimer Wins EU Approval for New Antibiotic
|
Luke Timmerman |
12/12/11 |
San Diego
|
|
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
11/10/11 |
San Diego
|
|
FDA Approves Optimer Antibiotic, Amylin Wins Legal Round Against Lilly, Investors Excited by Orexigen Move, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
06/02/11 |
San Diego
|
|
Optimer Cruises Into Memorable Memorial Day Weekend, Awaiting FDA Word on Antibiotic
|
Luke Timmerman |
05/27/11 |
San Diego
|
|
Optimer Antibiotic Gets Panel Nod, CareFusion Buys Vestara, Tracon Raises $16.5M, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
04/07/11 |
San Diego
|
|
Optimer Wins FDA Panel Nod, Still Wrestling With Language to Describe Benefit
|
Luke Timmerman |
04/05/11 |
San Diego
|
|
Biotechies Need to Get Serious About Antibiotics, Where There is Money to Be Made
|
Luke Timmerman |
04/04/11 |
National
|
|
Illumina Rides Business Surge, IntegenX Acquires GenValult, Orexigen Cuts Payroll, & More San Diego Life Science News
|
Bruce V. Bigelow |
02/10/11 |
San Diego
|
|
Optimer Pockets $68M Upfront From Astellas For Rights to Antibiotic in Europe
|
Luke Timmerman |
02/07/11 |
San Diego
|
|
Optimer Seeks Fast Review of Drug for Intestinal Infection, Histogen Raises $10M, TSRI Shares its “Click” Chemistry in Deal with Massachusetts Biotech, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
12/02/10 |
San Diego
|
|
Optimer Seeks Quick Green Light From FDA for Antibiotic Against Deadly Bug
|
Luke Timmerman |
11/30/10 |
San Diego
|
|
Optimer Halts Study After Antibiotic for Traveler’s Diarrhea Linked to Rash; Shares Drop
|
Luke Timmerman |
11/10/10 |
San Diego
|
|
Conatus Gets Idun, Trius Goes Public, BrainCells Gets Sabcomeline, & More San Diego-Area Life Sciences News
|
Bruce V. Bigelow |
08/05/10 |
San Diego
|
|
Optimer Hires New CEO
|
Luke Timmerman |
05/06/10 |
San Diego
|
|
Optimer Nets $51.5M
|
Luke Timmerman |
03/01/10 |
San Diego
|
|
Optimer Rises on Takeover Buzz and Clinical Trial Results; Still Faces Business Risks
|
Luke Timmerman |
02/08/10 |
San Diego
|
|
Optimer Passes Second Big Trial of Drug for Deadly Bacteria
|
Luke Timmerman |
02/04/10 |
San Diego
|
|
UK’s Enigma Diagnostics to Establish U.S. Headquarters in San Diego
|
Bruce V. Bigelow |
10/27/09 |
San Diego
|
|
Optimer Rides Investment See-Saw With Promising Drug for “C.diff” Infections
|
Luke Timmerman |
06/05/09 |
San Diego
|
|
Optimer To Seek EU Approval
|
Luke Timmerman |
03/02/09 |
San Diego
|
|
Optimer Shares Skyrocket, as Drug Halts Deadly Bacterial Infection in Trial
|
Luke Timmerman |
11/10/08 |
San Diego
|
|
Isis Spinoff Ibis Biosciences, Looking at DNA of Infectious Bugs, Aims to Identify What They Are, Faster
|
Luke Timmerman |
10/27/08 |
San Diego
|
|
Optimer, Developer of Drug For “C. Diff” Bacteria, Awaits Pivotal Results
|
Luke Timmerman |
10/23/08 |
San Diego
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.